Skip to main content
. 2009 Dec 4;106(49):809–820. doi: 10.3238/arztebl.2009.0809

Table 1. TNM classification of lung cancer in the 6th edition (5, 6) and proposal for the 7th edition (25).

6th edition Proposal for the 7th edition
T TX Primary tumor cannot be assessed, or evidence of malignant cells in sputum or bronchial lavage fluid but no visualization of tumor on imaging or bronchoscopy TX Primary tumor cannot be assessed, or evidence of malignant cells in sputum or bronchial lavage fluid but no visualization of tumor on imaging or bronchoscopy
T0 No evidence of primary tumor T0 No evidence of primary tumor
Tis Carcinoma in situ Tis Carcinoma in situ
T1 Tumor ≤ 3 cm greatest diameter, surrounded by lung tissue or visceral pleura, no bronchoscopic evidence of invasion proximal to the lobar bronchus (i.e., main bronchi are free)*1 T1 Tumor ≤ 3 cm greatest diameter, surrounded by lung tissue or visceral pleura, no bronchoscopic evidence of infiltration proximal to the lobar bronchus (i.e., main bronchi are free)*1
T1a Tumor ≤ 2 cm greatest diameter
T1b Tumor > 2 but ≤ 3 cm greatest diameter
T2 Tumor > 3 cm or tumor with one of the following features: T2 Tumor > 3 but ≤ 7 cm with one of the following features:
  • invasion of the main bronchus, ≥ 2 cm dis tal to the carina

  • invasion of the visceral pleura

  • associated atelectasis or obstructive pneumonia extending as far as the hilus but not involving the whole lung

  • invasion of the main bronchus ≥ 2 cm distal to the carina

  • invasion of the visceral pleura

Associated atelectasis or obstructive pneumonia extending as far as the hilus but not involving the whole lung
T2a Tumor > 3 but ≤ 5 cm greatest diameter
T2b Tumor > 5 but ≤ 7 cm greatest diameter
T3 Tumor of any size with direct invasion of one of the following structures: T3 Tumor > 7 cm or any tumor with direct invasion of one of the following structures:
  • chest wall (including tumors of the superior sulcus)

  • diaphragm

  • phrenic nerve

  • mediastinal pleura

  • parietal pericardium

  • chest wall (including tumors of the superior sulcus)

  • diaphragm

  • phrenic nerve

  • mediastinal pleura

  • parietal pericardium

or tumor in the main bronchus < 2 cm distal to the carina, without involvement of the carina and without associated atelectasis or obstructive pneumonia of the whole lung or tumor in the main bronchus < 2 cm distal to the carina, without involvement of the carina and without associated atelectasis or obstructive pneumonia of the whole lung or satellite tumor nodule(s) in the same lobe
T4 Tumor of any size invading one of the following structures: T4 Tumor of any size invading one of the following structures:
  • mediastinum

  • heart

  • great vessels

  • trachea

  • recurrent laryngeal nerve

  • esophagus

  • vertebral body

  • carina

  • mediastinum

  • heart

  • great vessels

  • trachea

  • recurrent laryngeal nerve

  • esophagus

  • vertebral body

  • carina

  • or separate tumor nodule(s) in another ipsilateral lobe

or separate tumor nodule(s) in the same lobe or tumor with malignant pleural* 2 or pericardial effusion
N NX Regional lymph nodes could not be evaluated NX Regional lymph nodes could not be evaluated
N0 No regional lymph node metastases N0 No regional lymph node metastases
N1 Metastasis/metastases in the ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension of the primary tumor N1 Metastasis/metastases in the ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension of the primary tumor
N2 Metastasis/metastases in the ipsilateral mediastinal and/or subcarinal lymph nodes N2 Metastasis/metastases in the ipsilateral mediastinal and/or subcarinal lymph nodes
N3 Metastasis/metastases in the contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene or supraclavicular lymph nodes N3 Metastasis/metastases in the contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene or supraclavicular lymph nodes
M MX Distant metastases could not be evaluated MX Distant metastases could not be evaluated
M0 No distant metastases M0 No distant metastases
M1 Distant metastases, including separate tumor nodules in another pulmonary lobe M1 Distant metastases
M1a Separate tumor nodule(s) in a contralateral lobe; tumor with pleural*2 nodes or malignant pleural (or pericardial) effusion
M1b Distant metastases

*1 A superficially extending tumor with invasion limited to the bronchial wall is always classified as T1.

*2 In patients with lung cancer, pleural and pericardial effusions are usually due to the tumor. In a few patients, however, if multiple cytological examinations are negative for the presence of tumor cells, the effusion is not hemorrhagic and is not an exudate. If these factors are present, and if the clinical evaluation also indicates that the effusion is not caused by the lung cancer, the effusion should not be taken into account as a staging criterion.